Simcere Pharmaceutical Group (NYSE:SCR)

CAPS Rating: 4 out of 5

The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.

Recs

0
Player Avatar Sqwii (< 20) Submitted: 6/4/2008 4:11:38 PM : Outperform Start Price: $15.01 SCR Score: -41.90

Bullish signal stocksabroad

Report this Post Reply

Featured Broker Partners


Advertisement